Abiopharma

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

New Form SCHEDULE 13G/A - Q32 Bio Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005207 <b>Size:</b> 9 KB

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Half Yearly Results

New Form S-8 - DDC Enterprise Ltd <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001213900-26-089486 <b>Size:</b> 578 KB

New Form SCHEDULE 13G - InflaRx N.V. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005206 <b>Size:</b> 14 KB

New Form SCHEDULE 13G/A - OneWater Marine Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000221 <b>Size:</b> 14 KB

New Form SCHEDULE 13G/A - X4 Pharmaceuticals, Inc <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001172661-26-003487 <b>Size:</b> 14 KB

Financial Statements and Related Announcement: Half Yearly Results

Financial Statements and Related Announcement: Second Quarter and/ or Half Yearly Results

New Form SCHEDULE 13G/A - Immunome Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005205 <b>Size:</b> 10 KB

General Announcement: NET TANGIBLE ASSETS ("NTA") PER UNIT

New Form SCHEDULE 13G - First Tracks Biotherapeutics, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000919574-26-005204 <b>Size:</b> 15 KB

New Form SCHEDULE 13G/A - KOHLS Corp <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0000052388-26-000219 <b>Size:</b> 14 KB

New Form 424B3 - Wheeler Real Estate Investment Trust, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001527541-26-000287 <b>Size:</b> 125 KB